OHDR Oncology™

OHDR Oncology™ Assessment

Patient context

Clinical Starter™

0 / 5 lifetime assessments used

5 remaining

Clinical progress1 / 4

Absolute Neutrophil Count (ANC)

Reference: >1000 normal · <500 critical (cells/µL)

Platelet Count

Reference: >100,000 normal · <50,000 high bleeding risk (cells/µL)

Recent Blood Test Availability

Days since last chemotherapy cycle

OHDR System™ provides clinical decision support and does not replace professional medical judgment.